Urology ultrasound sits at the intersection of diagnostic imaging and in-office procedure guidance. A prostate biopsy needs a transrectal probe and a platform that can visualize needle placement in real time. Renal stone evaluation requires a convex transducer with enough penetration depth to assess caliceal dilation and hydronephrosis. Bladder volume measurement and post-void residual quantification are fast, high-frequency studies often done at the point of the urology visit rather than sent out to imaging. The machine that handles all of this on a busy urology schedule earns consistently, and we structure financing to match that earning cadence.
The urology ultrasound market spans a wide price range: dedicated bladder scanners under $10,000 that do nothing but post-void residuals, general compact systems somewhere in the $25k–$70k band capable of renal and bladder evaluation, and full cart-based platforms with transrectal probe support and biopsy guidance capability that run $80,000 to $180,000. Our minimum transaction is $50,000, so we're most relevant for the mid-range and premium tier, though a practice bundling a bladder scanner with a primary platform can include both in a single transaction.